These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 29027122)

  • 21. [Pharmacology of neuroprotection in acute ischemic stroke].
    Fernández-Gómez FJ; Hernández F; Argandoña L; Galindo MF; Segura T; Jordán J
    Rev Neurol; 2008 Sep 1-15; 47(5):253-60. PubMed ID: 18780272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The intervention treatment of neuroprotection for ischemic stroke].
    Wang YL; Liang H; Song SL
    Sheng Li Ke Xue Jin Zhan; 2012 Aug; 43(4):279-82. PubMed ID: 23189623
    [No Abstract]   [Full Text] [Related]  

  • 23. Neuroprotection in acute ischaemic stroke. Current status and future potential.
    Lutsep HL; Clark WM
    Drugs R D; 1999 Jan; 1(1):3-8. PubMed ID: 10565968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination therapy for ischemic stroke: potential of neuroprotectants plus thrombolytics.
    Chen SD; Lee JM; Yang DI; Nassief A; Hsu CY
    Am J Cardiovasc Drugs; 2002; 2(5):303-13. PubMed ID: 14727960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evolving therapeutic approaches to treating acute ischemic stroke.
    Weinberger JM
    J Neurol Sci; 2006 Nov; 249(2):101-9. PubMed ID: 17005205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current status and perspectives of neuroprotection in ischemic stroke treatment.
    Martínez-Vila E; Sieira PI
    Cerebrovasc Dis; 2001; 11 Suppl 1():60-70. PubMed ID: 11244202
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeted delivery of intranasally administered nanoparticles-mediated neuroprotective peptide NR2B9c to brain and neuron for treatment of ischemic stroke.
    Li R; Huang Y; Chen L; Zhou H; Zhang M; Chang L; Shen H; Zhou M; Su P; Zhu D
    Nanomedicine; 2019 Jun; 18():380-390. PubMed ID: 30428334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time for a neurorestorative therapy in stroke.
    Jäkälä P; Jolkkonen J
    Expert Opin Biol Ther; 2012 Mar; 12(3):267-70. PubMed ID: 22251201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation by the Noble Gas Helium of Tissue Plasminogen Activator: Effects in a Rat Model of Thromboembolic Stroke.
    Haelewyn B; David HN; Blatteau JE; Vallée N; Meckler C; Risso JJ; Abraini JH
    Crit Care Med; 2016 Jun; 44(6):e383-9. PubMed ID: 26646461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroprotective effects of adjunctive treatments for acute stroke thrombolysis: a review of clinical evidence.
    Zhou H; Huang S; Sunnassee G; Guo W; Chen J; Guo Y; Tan S
    Int J Neurosci; 2017 Nov; 127(11):1036-1046. PubMed ID: 28110588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sub-acute systemic erythropoietin administration reduces ischemic brain injury in an age-dependent manner.
    Thériault P; Le Béhot A; ElAli A; Rivest S
    Oncotarget; 2016 Jun; 7(24):35552-35561. PubMed ID: 27248662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of combined therapy with thrombolysis and citicoline in a rat model of embolic stroke.
    Alonso de Leciñana M; Gutiérrez M; Roda JM; Carceller F; Díez-Tejedor E
    J Neurol Sci; 2006 Sep; 247(2):121-9. PubMed ID: 16797595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model.
    Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G
    Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine improves safety of thrombolysis for stroke.
    Montagne A; Hébert M; Jullienne A; Lesept F; Le Béhot A; Louessard M; Gauberti M; Orset C; Ali C; Agin V; Maubert E; Vivien D
    Stroke; 2012 Oct; 43(10):2774-81. PubMed ID: 22879098
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigational therapies for ischemic stroke: neuroprotection and neurorecovery.
    Sahota P; Savitz SI
    Neurotherapeutics; 2011 Jul; 8(3):434-51. PubMed ID: 21604061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current state on development of neuroprotective agents for cerebral ischemia].
    Hirouchi M; Ukai Y
    Nihon Yakurigaku Zasshi; 2002 Aug; 120(2):107-13. PubMed ID: 12187623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuroprotective strategies and the underlying molecular basis of cerebrovascular stroke.
    Karsy M; Brock A; Guan J; Taussky P; Kalani MY; Park MS
    Neurosurg Focus; 2017 Apr; 42(4):E3. PubMed ID: 28366066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroprotection in acute ischemic stroke.
    De Keyser J; Uyttenboogaart M; Koch MW; Elting JW; Sulter G; Vroomen PC; Luijckx GJ
    Acta Neurol Belg; 2005 Sep; 105(3):144-8. PubMed ID: 16255152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current therapies in ischemic stroke. Part B. Future candidates in stroke therapy and experimental studies.
    Broussalis E; Trinka E; Killer M; Harrer A; McCoy M; Kraus J
    Drug Discov Today; 2012 Jul; 17(13-14):671-84. PubMed ID: 22405898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel therapies for acute ischemic stroke.
    Leker RR; Eichel R; Rafaeli G; Ben-Hur T
    Isr Med Assoc J; 2006 Nov; 8(11):788-92. PubMed ID: 17180832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.